Physician profile
Michael A Wells
NPI 1205838927
$345.83
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $44.01 · 2021: $155.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $134.76 | 2021 | |
| Abbvie INC. | $68.59 | 2019-2020 | |
| Hologic Sales and Service, LLC | $46.36 | 2019-2020 | |
| Csl Behring | $19.86 | 2021 | |
| Covidien LP | $14.17 | 2019 | |
| Olympus America INC. | $13.62 | 2019 | |
| Avanos Medical | $13.07 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.28 | 2019 | |
| Evofem Biosciences, INC. | $11.62 | 2020 | |
| Becton, Dickinson and Company | $11.50 | 2019 |
2 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.